Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt · Delayed Price · Currency is EGP

4.070

-0.030 (-0.73%)

At close: Apr 2, 2026

EGX:RMDA Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,140	6,660	5,022	2,459	2,892	2,400
Market Cap Growth	30.15%	32.63%	104.18%	-14.96%	20.51%	-18.04%
Enterprise Value	10,489	8,919	5,881	3,259	3,284	3,006
Last Close Price	4.07	3.33	2.46	1.18	1.40	1.12
PE Ratio	30.46	22.31	13.80	11.00	12.63	14.42
Forward PE	13.83	9.19	10.84	7.72	9.25	10.10
PS Ratio	1.99	1.63	1.81	1.28	1.95	1.93
PB Ratio	3.68	3.01	2.42	1.39	1.90	1.78
P/TBV Ratio	7.70	6.30	3.37	2.10	2.73	2.50
P/FCF Ratio	-	-	-	-	-	12.72
P/OCF Ratio	-	-	-	-	98.55	9.94
PEG Ratio	-	0.28	0.28	0.28	0.28	0.27
EV/Sales Ratio	2.56	2.18	2.12	1.70	2.21	2.41
EV/EBITDA Ratio	9.97	8.48	7.33	6.33	8.14	9.49
EV/EBIT Ratio	10.93	9.29	8.14	7.31	9.60	10.96
EV/FCF Ratio	-52.56	-	-	-	-	15.93
Debt / Equity Ratio	1.06	1.06	0.76	0.63	0.61	0.65
Debt / EBITDA Ratio	2.23	2.23	1.94	2.15	2.28	2.75
Debt / FCF Ratio	-	-	-	-	-	4.66
Net Debt / Equity Ratio	1.04	1.04	0.63	0.45	0.33	0.30
Net Debt / EBITDA Ratio	2.19	2.19	1.64	1.56	1.24	1.26
Net Debt / FCF Ratio	-11.56	-11.56	-3.53	-5.91	-99.72	2.11
Asset Turnover	0.85	0.85	0.74	0.64	0.57	0.53
Inventory Turnover	2.37	2.37	2.82	3.13	2.52	2.37
Quick Ratio	0.72	0.72	0.53	0.54	0.62	0.76
Current Ratio	1.15	1.15	1.46	1.47	1.49	1.44
Return on Equity (ROE)	14.63%	14.63%	20.89%	15.35%	17.63%	14.24%
Return on Assets (ROA)	12.44%	12.44%	12.00%	9.30%	8.24%	7.34%
Return on Invested Capital (ROIC)	15.93%	17.95%	18.53%	14.98%	13.99%	12.53%
Return on Capital Employed (ROCE)	40.80%	40.80%	33.50%	24.20%	21.50%	19.60%
Earnings Yield	3.67%	4.48%	7.71%	9.96%	8.49%	7.54%
FCF Yield	-2.45%	-3.00%	-7.41%	-5.51%	-0.17%	7.86%
Dividend Yield	0.99%	-	1.63%	4.29%	-	-
Payout Ratio	63.29%	63.30%	31.31%	6.85%	9.89%	8.12%
Buyback Yield / Dilution	-4.44%	-12.16%	-0.23%	-1.27%	2.62%	-
Total Shareholder Return	-3.46%	-12.16%	1.41%	3.02%	2.62%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.